Livzon Pharmaceutical Group Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Zhuhai, Guangdong and currently employs 9,067 full-time employees. Livzon Pharmaceutical Group Inc is a China-based company principally engaged in the research, development, production and sale of pharmaceutical products. The firm's main businesses include chemical drug preparations, biological products, active pharmaceutical ingredients and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, commercial development and functional management. The firm's main products include Ilaprazole (Ilaprazole Enteric-Coated Tablets and Ilaprazole Sodium for Injection), a series of Bismuth Potassium Citrate products, Rabeprazole Sodium Enteric-Coated Capsules, Weisanlian (Bismuth Potassium Citrate Tablets/Tinidazole Tablets/Clarithromycin Tablets), Leuprorelin Acetate Microspheres for Injection, Urofollitropin for Injection, Menotropins for Injection, Voriconazole for Injection and others. The firm mainly operates its businesses in the domestic and overseas markets.
根据最新的财务报表(Form-10K),Livzon Pharmaceutical Group Inc. 的总资产为 $24,455,净利润为 $2,061
LVZPF 的关键财务比率是什么?
Livzon Pharmaceutical Group Inc. 的流动比率是 2.3,净利 margin 为 17.44,每股销售为 $12.83。
Livzon Pharmaceutical Group Inc. 的收入按细分市场或地理位置如何划分?
Livzon Pharmaceutical Group Inc. 最大收入来源是 Chemical Drug Preparations,在最近的收益报告中收入为 6,119,280,577。就地区而言, China 是 Livzon Pharmaceutical Group Inc. 的主要市场,收入为 9,976,999,763。
Livzon Pharmaceutical Group Inc. 是否盈利?
是的,根据最新的财务报表,Livzon Pharmaceutical Group Inc. 的净利润为 $2,061